Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Explore the best credit card rewards program that suits your lifestyle and spending habits. Maximize your benefits and earn rewards with ease.
15,544 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
The SpaceX sell-off is showing signs of worsening momentum, but patient investors can still navigate it with a discip...
Curious about a long term reason to own Pfizer? This guide lays out a practical, actionable case for buying and holdi...
Broadcom stands at a pivotal crossroads as AI spending shifts from pilots to production. This article lays out the ke...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...
Broadcom faced a rough June as the stock fell about 15%. This article breaks down what happened, why it matters, and ...
What if the best gains come from stocks you didn’t expect? This guide shows how unexpected stock picks looking ahead ...
When a legendary brand names a new leader, investors lean in. Disney's CEO, Josh D'Amaro, arrives with a plan to shar...
Microsoft stock sinking today has investors looking past a single bad headline. This deep-dive explains the drivers b...
A routine 2026 cash-out from a CD ladder could lift Medicare premiums in 2028 due to IRMAA lookback rules. Retirees s...
Energy markets moved on geopolitical headlines, lifting ConocoPhillips stock in intraday trading. This article explai...